Table of Content

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Billion)
1.2.1. Over the Counter (OTC) Drugs Market, by Region, 2018-2027 (USD Billion)
1.2.2. Over the Counter (OTC) Drugs Market, by Product Type, 2018-2027 (USD Billion)
1.2.3. Over the Counter (OTC) Drugs Market, by Distribution Channel, 2018-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Over the Counter (OTC) Drugs Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Over the Counter (OTC) Drugs Market Dynamics
3.1. Over the Counter (OTC) Drugs Market Impact Analysis (2018-2027)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global Over the Counter (OTC) Drugs Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2017-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Over the Counter (OTC) Drugs Market, by Product Type
5.1. Market Snapshot
5.2. Global Over the Counter (OTC) Drugs Market by Product Type, Performance - Potential Analysis
5.3. Global Over the Counter (OTC) Drugs Market Estimates & Forecasts by Product Type 2017-2027 (USD Billion)
5.4. Over the Counter (OTC) Drugs Market, Sub Segment Analysis
5.4.1. Cough, Cold, and Flu Products
5.4.2. Analgesics
5.4.3. Dermatology Products
5.4.4. Gastrointestinal Products
5.4.5. Vitamins, Mineral, and Supplements (VMS)
5.4.6. Weight-loss/Dietary Products
5.4.7. Others
Chapter 6. Global Over the Counter (OTC) Drugs Market, by Distribution Channel
6.1. Market Snapshot
6.2. Global Over the Counter (OTC) Drugs Market by Distribution Channel, Performance - Potential Analysis
6.3. Global Over the Counter (OTC) Drugs Market Estimates & Forecasts by Distribution Channel 2017-2027 (USD Billion)
6.4. Over the Counter (OTC) Drugs Market, Sub Segment Analysis
6.4.1. Hospital Pharmacies
6.4.2. Retail Pharmacies
6.4.3. Online Pharmacy
6.4.4. Others
Chapter 7. Global Over the Counter (OTC) Drugs Market, Regional Analysis
7.1. Over the Counter (OTC) Drugs Market, Regional Market Snapshot
7.2. North America Over the Counter (OTC) Drugs Market
7.2.1. U.S. Over the Counter (OTC) Drugs Market
7.2.1.1. Product Type breakdown estimates & forecasts, 2017-2027
7.2.1.2. Distribution Channel breakdown estimates & forecasts, 2017-2027
7.2.2. Canada Over the Counter (OTC) Drugs Market
7.3. Europe Over the Counter (OTC) Drugs Market Snapshot
7.3.1. U.K. Over the Counter (OTC) Drugs Market
7.3.2. Germany Over the Counter (OTC) Drugs Market
7.3.3. Rest of Europe Over the Counter (OTC) Drugs Market
7.4. Asia-Pacific Over the Counter (OTC) Drugs Market Snapshot
7.4.1. China Over the Counter (OTC) Drugs Market
7.4.2. India Over the Counter (OTC) Drugs Market
7.4.3. Japan Over the Counter (OTC) Drugs Market
7.4.4. Rest of Asia Pacific Over the Counter (OTC) Drugs Market
7.5. Latin America Over the Counter (OTC) Drugs Market Snapshot
7.5.1. Brazil Over the Counter (OTC) Drugs Market
7.5.2. Mexico Over the Counter (OTC) Drugs Market
7.6. Rest of The World Over the Counter (OTC) Drugs Market
Chapter 8. Competitive Intelligence
8.1. Top Market Strategies
8.2. Company Profiles
8.2.1. Johnson and Johnson
8.2.1.1. Key Information
8.2.1.2. Overview
8.2.1.3. Financial (Subject to Data Availability)
8.2.1.4. Product Summary
8.2.1.5. Recent Developments
8.2.2. Novartis AG
8.2.3. Bayer AG
8.2.4. Sanofi S.A.
8.2.5. Pfizer Inc.
8.2.6. GlaxoSmithKline PLC
8.2.7. Perrigo Company PLC
8.2.8. Reckitt Benckiser Group PLC
8.2.9. Takeda Pharmaceutical Company Ltd.
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption



List of Figures


FIG 1. GLOBAL OVER THE COUNTER (OTC) DRUGS MARKET, RESEARCH METHODOLOGY
FIG 2. GLOBAL OVER THE COUNTER (OTC) DRUGS MARKET, MARKET ESTIMATION TECHNIQUES
FIG 3. GLOBAL MARKET SIZE ESTIMATES & FORECAST METHODS
FIG 4. GLOBAL OVER THE COUNTER (OTC) DRUGS MARKET, KEY TRENDS 2019
FIG 5. GLOBAL OVER THE COUNTER (OTC) DRUGS MARKET, GROWTH PROSPECTS 2020-2027
FIG 6. GLOBAL OVER THE COUNTER (OTC) DRUGS MARKET, PORTERS 5 FORCE MODEL
FIG 7. GLOBAL OVER THE COUNTER (OTC) DRUGS MARKET, PEST ANALYSIS
FIG 8. GLOBAL OVER THE COUNTER (OTC) DRUGS MARKET, VALUE CHAIN ANALYSIS
FIG 9. GLOBAL OVER THE COUNTER (OTC) DRUGS MARKET BY SEGMENT, 2017 & 2027 (USD BILLION)
FIG 10. GLOBAL OVER THE COUNTER (OTC) DRUGS MARKET BY SEGMENT, 2017 & 2027 (USD BILLION)
FIG 11. GLOBAL OVER THE COUNTER (OTC) DRUGS MARKET BY SEGMENT, 2017 & 2027 (USD BILLION)
FIG 12. GLOBAL OVER THE COUNTER (OTC) DRUGS MARKET BY SEGMENT, 2017 & 2027 (USD BILLION)
FIG 13. GLOBAL OVER THE COUNTER (OTC) DRUGS MARKET BY SEGMENT, 2017 & 2027 (USD BILLION)
FIG 14. GLOBAL OVER THE COUNTER (OTC) DRUGS MARKET, REGIONAL SNAPSHOT 2017 & 2027
FIG 15. NORTH AMERICA OVER THE COUNTER (OTC) DRUGS MARKET 2017 & 2027 (USD BILLION)
FIG 16. EUROPE OVER THE COUNTER (OTC) DRUGS MARKET 2017 & 2027 (USD BILLION)
FIG 17. ASIA PACIFIC OVER THE COUNTER (OTC) DRUGS MARKET 2017 & 2027 (USD BILLION)
FIG 18. LATIN AMERICA OVER THE COUNTER (OTC) DRUGS MARKET 2017 & 2027 (USD BILLION)
FIG 19. GLOBAL OVER THE COUNTER (OTC) DRUGS MARKET, COMPANY MARKET SHARE ANALYSIS (2019)


List of Tables


TABLE 1. GLOBAL OVER THE COUNTER (OTC) DRUGS MARKET, REPORT SCOPE
TABLE 2. GLOBAL OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS BY REGION 2017-2027 (USD BILLION)
TABLE 3. GLOBAL OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS BY PRODUCT TYPE 2017-2027 (USD BILLION)
TABLE 4. GLOBAL OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS BY DISTRIBUTION CHANNEL 2017-2027 (USD BILLION)
TABLE 5. GLOBAL OVER THE COUNTER (OTC) DRUGS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 6. GLOBAL OVER THE COUNTER (OTC) DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 7. GLOBAL OVER THE COUNTER (OTC) DRUGS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 8. GLOBAL OVER THE COUNTER (OTC) DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 9. GLOBAL OVER THE COUNTER (OTC) DRUGS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 10. GLOBAL OVER THE COUNTER (OTC) DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 11. GLOBAL OVER THE COUNTER (OTC) DRUGS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 12. GLOBAL OVER THE COUNTER (OTC) DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 13. GLOBAL OVER THE COUNTER (OTC) DRUGS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 14. GLOBAL OVER THE COUNTER (OTC) DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 15. U.S. OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 16. U.S. OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 17. U.S. OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 18. CANADA OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 19. CANADA OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 20. CANADA OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 21. UK OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 22. UK OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 23. UK OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 24. GERMANY OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 25. GERMANY OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 26. GERMANY OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 27. ROE OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 28. ROE OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 29. ROE OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 30. CHINA OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 31. CHINA OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 32. CHINA OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 33. INDIA OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 34. INDIA OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 35. INDIA OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 36. JAPAN OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 37. JAPAN OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 38. JAPAN OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 39. ROAPAC OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 40. ROAPAC OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 41. ROAPAC OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 42. BRAZIL OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 43. BRAZIL OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 44. BRAZIL OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 45. MEXICO OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 46. MEXICO OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 47. MEXICO OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 48. ROLA OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 49. ROLA OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 50. ROLA OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 51. ROW OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 52. ROW OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 53. ROW OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 54. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF GLOBAL OVER THE COUNTER (OTC) DRUGS MARKET
TABLE 55. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF GLOBAL OVER THE COUNTER (OTC) DRUGS MARKET
TABLE 56. YEARS CONSIDERED FOR THE STUDY
TABLE 57. EXCHANGE RATES CONSIDERED